Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II trials of pamrevlumab

By sjmartinez • May 13, 2025

Kim GH, Zhang X, Brown MS, Poole L, Goldin J. Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II trials of pamrevlumab. BMJ Open. 2025 May 12;15(5):e094559. doi: 10.1136/bmjopen-2024-094559. PMID: 40355288.

Tags: Chest imaging, Computed tomography, interstitial lung disease, Patient reported outcome measures, Publications, Pulmonary Disease, Pulmonary, Critical Care & Sleep Medicine, QUALITATIVE RESEARCH

Brief Report: Association of HIV and HCV With Adverse Coronary Artery Phenotypes in Women: Findings From a Cross-Sectional Study

Shitole SG, Chen E, Naveed M, Xue X, Sharma A, Hanna DB, Anastos K, Kaplan RC, Levsky JM, Tien PC, Radparvar AA, Bortnick AE, Budoff[...]

Urine-guided Hydration and Kidney Injury: Comment

Delaporte A, Maghen B, Grogan T, Legrand M, Joosten A. Urine-guided Hydration and Kidney Injury: Comment. Anesthesiology. 2026 Apr 9. doi: 10.1097/ALN.0000000000006003. Epub ahead of[...]

Mechanisms of resistance to Tmprss6 antisense oligonucleotides in a mouse model of β-thalassemia

Zhang V, Barrett TD, Nemeth E, Ganz T. Mechanisms of resistance to Tmprss6 antisense oligonucleotides in a mouse model of β-thalassemia. Blood. 2026 Apr 9:blood.2026033274.[...]